These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35723175)
1. Molecular Testing for Indeterminate Thyroid Nodules: Association of Negative Predictive Value With Nodule Size. Barnes AB; Justice-Clark T; Li W; Randle RW Am Surg; 2022 Nov; 88(11):2745-2751. PubMed ID: 35723175 [TBL] [Abstract][Full Text] [Related]
2. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice. Witt RL Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717 [TBL] [Abstract][Full Text] [Related]
3. How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules? Steinmetz D; Kim M; Choi JH; Yeager T; Samuel K; Khajoueinejad N; Buseck A; Imtiaz S; Fernandez-Ranvier G; Lee D; Owen R; Taye A World J Surg; 2022 Dec; 46(12):3043-3050. PubMed ID: 36167834 [TBL] [Abstract][Full Text] [Related]
4. Molecular Testing Has Limited Utility in the Surgical Evaluation of Bethesda III Thyroid Nodules. Scola WH; Linhares SM; Handelsman RS; Picado O; Khan ZF; Farrá JC; Lew JI J Surg Res; 2021 Dec; 268():209-213. PubMed ID: 34358733 [TBL] [Abstract][Full Text] [Related]
5. Clinical performance of a next-generation sequencing assay (ThyroSeq v2) in the evaluation of indeterminate thyroid nodules. Taye A; Gurciullo D; Miles BA; Gupta A; Owen RP; Inabnet WB; Beyda JN; Marti JL Surgery; 2018 Jan; 163(1):97-103. PubMed ID: 29154079 [TBL] [Abstract][Full Text] [Related]
6. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules. Gortakowski M; Feghali K; Osakwe I Thyroid; 2021 Sep; 31(9):1376-1382. PubMed ID: 33764195 [No Abstract] [Full Text] [Related]
7. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial. Livhits MJ; Zhu CY; Kuo EJ; Nguyen DT; Kim J; Tseng CH; Leung AM; Rao J; Levin M; Douek ML; Beckett KR; Cheung DS; Gofnung YA; Smooke-Praw S; Yeh MW JAMA Oncol; 2021 Jan; 7(1):70-77. PubMed ID: 33300952 [TBL] [Abstract][Full Text] [Related]
8. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience. Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257 [TBL] [Abstract][Full Text] [Related]
9. Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3. Kim NE; Raghunathan RS; Hughes EG; Longstaff XR; Tseng CH; Li S; Cheung DS; Gofnung YA; Famini P; Wu JX; Yeh MW; Livhits MJ J Clin Endocrinol Metab; 2023 Aug; 108(9):e698-e703. PubMed ID: 36995878 [TBL] [Abstract][Full Text] [Related]
10. Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules. Wu JX; Young S; Hung ML; Li N; Yang SE; Cheung DS; Yeh MW; Livhits MJ Thyroid; 2016 Jul; 26(7):916-22. PubMed ID: 27161519 [TBL] [Abstract][Full Text] [Related]
11. Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules. Marcadis AR; Valderrabano P; Ho AS; Tepe J; Swartzwelder CE; Byrd S; Sacks WL; Untch BR; Shaha AR; Xu B; Lin O; Ghossein RA; Wong RJ; Marti JL; Morris LGT Surgery; 2019 Jan; 165(1):17-24. PubMed ID: 30360906 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology. Valderrabano P; Khazai L; Leon ME; Thompson ZJ; Ma Z; Chung CH; Hallanger-Johnson JE; Otto KJ; Rogers KD; Centeno BA; McIver B Endocr Relat Cancer; 2017 Mar; 24(3):127-136. PubMed ID: 28104680 [TBL] [Abstract][Full Text] [Related]
13. The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules. Hu TX; Nguyen DT; Patel M; Beckett K; Douek M; Masamed R; Rhyu J; Kim J; Tseng CH; Yeh MW; Livhits MJ Thyroid; 2022 Aug; 32(8):905-916. PubMed ID: 35611970 [No Abstract] [Full Text] [Related]
14. Evaluation of 167 Gene Expression Classifier (GEC) and ThyroSeq v2 Diagnostic Accuracy in the Preoperative Assessment of Indeterminate Thyroid Nodules: Bivariate/HROC Meta-analysis. Borowczyk M; Szczepanek-Parulska E; Olejarz M; Więckowska B; Verburg FA; Dębicki S; Budny B; Janicka-Jedyńska M; Ziemnicka K; Ruchała M Endocr Pathol; 2019 Mar; 30(1):8-15. PubMed ID: 30591992 [TBL] [Abstract][Full Text] [Related]
19. An update on the status of molecular testing for the indeterminate thyroid nodule and risk stratification of differentiated thyroid cancer. Nicholson KJ; Yip L Curr Opin Oncol; 2018 Jan; 30(1):8-15. PubMed ID: 29028645 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger. Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]